Neuroprotective Properties of Linagliptin: Focus on Biochemical Mechanisms in Cerebral Ischemia, Vascular Dysfunction and Certain Neurodegenerative Diseases

Linagliptin is a representative of dipeptidyl peptidase 4 (DPP-4) inhibitors which are registered and used effectively in a treatment of diabetes mellitus type 2. They increase the levels of active forms of endogenous incretins such as GLP-1 and GIP by inhibiting their enzymatic decomposition. Scien...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiciński, Michał, Górski, Karol, Walczak, Maciej, Wódkiewicz, Eryk, Słupski, Maciej, Pawlak-Osińska, Katarzyna, Malinowski, Bartosz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719127/
https://www.ncbi.nlm.nih.gov/pubmed/31434198
http://dx.doi.org/10.3390/ijms20164052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719127/
https://www.ncbi.nlm.nih.gov/pubmed/31434198
http://dx.doi.org/10.3390/ijms20164052

Ejemplares similares